Anavex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.About AVXL
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.
AVXL Key Statistics
Stock Snapshot
As of today, Anavex(AVXL) shares are valued at $2.86. The company's market cap stands at 265.58M, with a P/E ratio of -18.87.
On 2026-09-06, Anavex(AVXL) stock moved within a range of $2.81 to $2.96. With shares now at $2.86, the stock is trading +1.8% above its intraday low and -3.3% below the session's peak.
Trading activity shows a volume of 305.25K, compared to an average daily volume of 883.69K.
The stock's 52-week range extends from a low of $2.26 to a high of $10.40.
The stock's 52-week range extends from a low of $2.26 to a high of $10.40.
AVXL News
PVG Asset Management Corp., a stockholder of Anavex (AVXL) Life Sciences Corp., sent an open letter to the stockholders of Anavex. In its letter, PVG details wh...
The latest announcement is out from Anavex Life Sciences ( (AVXL) ). On May 20, 2026, Anavex Life Sciences received a delinquency notice from Nasdaq after fail...
Anavex (AVXL) Life Sciences announced that it has received confirmation from the Nasdaq Stock Market that the company has regained compliance with periodic fili...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.